New treatment methods in verapamil poisoning: experimental studies

Area of Science:

• Pharmacology
• Toxicology
• Cardiovascular Research

Background:

• Verapamil poisoning presents a significant clinical challenge due to its cardiotoxic effects.
• Current treatments for verapamil overdose have limitations.
• Novel therapeutic strategies are needed to improve patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of 4-aminopyridine (4-AP) and Bay K 8644 in treating experimentally induced verapamil poisoning in rats.
• To compare the effectiveness of 4-AP and Bay K 8644 with established treatments like adrenaline and calcium compounds.

Main Methods:

• Male and female Wistar rats were used, divided into control and treatment groups.
• Verapamil was administered to induce poisoning, characterized by a 50% reduction in mean arterial pressure and/or heart rate.
• Treatment groups received calcium glucolactobionicum, adrenaline, 4-AP, or Bay K 8644, with physiological parameters monitored throughout.

Main Results:

• 4-AP and Bay K 8644 significantly reduced mortality compared to the control group (p < 0.005 and p < 0.01, respectively).
• Adrenaline also showed a significant decrease in mortality (p < 0.05).
• 4-AP and Bay K 8644 rapidly reversed poisoning symptoms, including increased blood pressure, heart rate, and resolution of bradyarrhythmia.

Conclusions:

• 4-aminopyridine (4-AP) and Bay K 8644 demonstrate significant potential as effective treatments for verapamil poisoning.
• These agents offer rapid symptom reversal and improved survival rates in experimental models.
• Further investigation into their clinical application for verapamil overdose is warranted.